Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Journal of Immunology Research|November 23, 2016
Attention Deficit Disorder and Allergic Rhinitis: Are They Related?Isaac Melamed, Melinda HeffronInternational Reviews of Immunology|December 11, 2012
Subcutaneous immunoglobulins: product characteristics and their role in primary immunodeficiency diseaseIsaac Melamed, Alessandro Testori, Zvi SpirerEuropean Journal of Pharmacology|May 6, 2015
Mast cells, brain inflammation and autismTheoharis C Theoharides, Julia M Stewart, Smaro Panagiotidou, et al.Cellular and Molecular Neurobiology|May 19, 2026
C1-esterase Inhibitor Treatment is Associated with Immune and Vascular Pathway Modulation in PASC with Neurological Symptoms: Longitudinal Plasma ProteomicsNoga Orr, Maureen Collins, Shawn Novak, et al.Protein and Peptide Letters|February 14, 2006
Autoantibody reaction to myelin basic protein by plasma parvovirus B19 IgG in MS patientsGregory Thomas, Leonard Rael, Rick Shimonkevitz, et al.CPT: Pharmacometrics & Systems Pharmacology|May 31, 2026
Pharmacokinetic Model Based Sensitivity Analysis to Lower Recruitment Burden for Young Children Requiring Intravenous Immunoglobulin G ReplacementTodd Dumas, Shahram Mehr, Rebecca Avila, et al.Frontiers in Neurology|November 24, 2025
Does C1 esterase inhibitor play a role in post COVID-19 neurological symptoms? A randomized, double-blind, placebo-controlled, crossover, proof-of-concept studyIsaac Melamed, Caley Buckley, Mary Ellen Bayko, et al.Journal of Clinical Immunology|June 26, 2016
Pharmacokinetics, Safety, and Tolerability of Subcutaneous Immune Globulin Injection (Human), 10 % Caprylate/Chromatography Purified (GAMUNEX®-C) in Pediatric Patients with Primary Immunodeficiency DiseaseJennifer Heimall, Junliang Chen, Joseph A Church, et al.Frontiers in Immunology|October 18, 2024
IVIG response in pediatric acute-onset neuropsychiatric syndrome correlates with reduction in pro-inflammatory monocytes and neuropsychiatric measuresIsaac Melamed, Shamma Rahman, Heather Pein, et al.Journal of Clinical Immunology|May 5, 2007
Carimune NF Liquid is a safe and effective immunoglobulin replacement therapy in patients with primary immunodeficiency diseasesMelvin Berger, Charlotte Cunningham-Rundles, Francisco A Bonilla, et al.Pageof 4